about
Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins.Impact of bone marrow stromal cells on Bcl-2 family members in chronic lymphocytic leukemia.Death receptors in chemotherapy and cancer.Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alphaNovel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia.Mechanisms of PECAM-1-mediated cytoprotection and implications for cancer cell survival.Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy.Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia.AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistanceVDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia.STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens.Signaling pathways activated by the B-cell receptor in chronic lymphocytic leukemia.Toll-like receptors targeting technology for the treatment of lymphoma.Apoptotic effect of oridonin on NB4 cells and its mechanism.Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity.Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemia.Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells.The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia.
P2860
Q33345150-040FEE17-DB2B-4A48-B1B1-4CA0DE2671BDQ34231324-A701AA6D-162E-4398-A0D8-6F3B4989C170Q35743149-54C43232-3CC8-4D8D-9CEF-4843E00F598CQ35847913-96329D2B-7630-4756-A3F5-86F558490B15Q35990061-4FC3A45D-E094-490B-A7C9-9E9433AA6C2AQ36085962-369B4D7F-3F3C-4125-89F5-E2B5DD419643Q36272597-FCFD37D3-62D4-4F6A-B49B-B638567CC0A4Q36623633-D3061677-8B7A-4993-8C97-7608EA8067BAQ36635059-1E9E0BB4-E6E9-4542-B3D3-357E64129590Q37039117-F70170DF-5D46-4846-AF96-77CD0255884AQ37211985-7229ACEB-720E-4CE8-9584-A89A2CC44852Q37306304-4675C627-1F54-4249-8325-213AF6458E56Q37362593-9D35A443-21E3-4281-A7AF-10AA25000A58Q37838167-6EB63137-7146-416D-BF8C-11DF27583895Q38025162-6D190891-070C-4EEB-8FD6-12902B051E77Q38948266-A4CCC18A-AA49-4488-BC7D-4661B20BB645Q40397708-BAEBE725-D5BD-48DF-8AFE-A9D1D0891980Q40439092-EF72CC4B-AF6C-4A96-A9D3-7D15966D53A4Q42134533-C8F8DD3D-CE76-4271-9D20-076230FFAA1AQ44905141-5450F1F6-489B-4D39-86BE-2C41EE953D4DQ50970605-4346C804-C0FC-4326-84B1-EE13100489D6Q51028667-BD06E9BC-C359-40A2-A807-CECFBA11F890Q54385532-DD71CE53-EB6C-48AD-8E58-CCEC04D973C2
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Bcl-2 and apoptosis in chronic lymphocytic leukemia.
@ast
Bcl-2 and apoptosis in chronic lymphocytic leukemia.
@en
type
label
Bcl-2 and apoptosis in chronic lymphocytic leukemia.
@ast
Bcl-2 and apoptosis in chronic lymphocytic leukemia.
@en
prefLabel
Bcl-2 and apoptosis in chronic lymphocytic leukemia.
@ast
Bcl-2 and apoptosis in chronic lymphocytic leukemia.
@en
P2093
P1476
Bcl-2 and apoptosis in chronic lymphocytic leukemia.
@en
P2093
Aaron D Schimmer
Irene Munk-Pedersen
John C Reed
Mark D Minden
P2888
P304
P356
10.1007/S11864-003-0022-Y
P577
2003-06-01T00:00:00Z